{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:21:17Z","timestamp":1784330477554,"version":"3.55.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sanofi"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novartis"},{"name":"AstraZeneca"},{"name":"Roche"},{"DOI":"10.13039\/100009947","name":"Merck, Sharp & Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.2217\/imt-2017-0167","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T08:43:40Z","timestamp":1521708220000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Family History of Cancer as Surrogate Predictor for Immunotherapy with Anti-Pd1\/Pd-L1 Agents: Preliminary Report of the\n            <i>Fami-L1<\/i>\n            Study"],"prefix":"10.1080","volume":"10","author":[{"given":"Alessio","family":"Cortellini","sequence":"first","affiliation":[{"name":"Medical Oncology Unit, St Salvatore Hospital, Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, Via Vetoio, 67100, L\u2019Aquila, Italy"},{"name":"Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bersanelli","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Buti","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Gambale","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, SS Annunziata Hospita, Chieti, Italy"},{"name":"Department of Medical, Oral &amp; Biotechnological Sciences University G. D\u2019Annunzio, Chieti-Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Atzori","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zoratto","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, F. Spaziani Hospital, Frosinone, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Parisi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, St Salvatore Hospital, Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, Via Vetoio, 67100, L\u2019Aquila, Italy"},{"name":"Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Brocco","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, SS Annunziata Hospita, Chieti, Italy"},{"name":"Department of Medical, Oral &amp; Biotechnological Sciences University G. D\u2019Annunzio, Chieti-Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagrazia","family":"Pireddu","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Cannita","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, St Salvatore Hospital, Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, Via Vetoio, 67100, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[{"name":"Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R","family":"Migliorino","sequence":"additional","affiliation":[{"name":"Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gamucci","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, F. Spaziani Hospital, Frosinone, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Tursi","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, SS Annunziata Hospita, Chieti, Italy"},{"name":"Department of Medical, Oral &amp; Biotechnological Sciences University G. D\u2019Annunzio, Chieti-Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Sidoni","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, St Salvatore Hospital, Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, Via Vetoio, 67100, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Michiara","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselmo","family":"Papa","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences &amp; Biotechnologies, University of Rome \u2018Sapienza; Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesuino","family":"Angius","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences &amp; Biotechnologies, University of Rome \u2018Sapienza; Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Tomao","sequence":"additional","affiliation":[{"name":"Oncology Unit, Department of Radiological Sciences, Oncology &amp; Pathology, University of Rome \u2018Sapienza;, Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Fargnoli","sequence":"additional","affiliation":[{"name":"Oncological Dermatology Unit, San Salvatore Hospital, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Natoli","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, SS Annunziata Hospita, Chieti, Italy"},{"name":"Department of Medical, Oral &amp; Biotechnological Sciences &amp; CeSI-MeT, University of Chieti-Pescara, Chieti and Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Ficorella","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, St Salvatore Hospital, Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, Via Vetoio, 67100, L\u2019Aquila, Italy"},{"name":"Department of Biotechnological &amp; Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3271"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32517-X"},{"issue":"3005","key":"e_1_3_3_5_1","article-title":"Clinical efficacy and correlation with tumor PD-L1 expression in patients with melanoma treated with the anti-PD-1 monoclonal antibody MK-3475","volume":"32","author":"Kefford R","year":"2014","unstructured":"Kefford R , RibasA , HamidAet al. Clinical efficacy and correlation with tumor PD-L1 expression in patients with melanoma treated with the anti-PD-1 monoclonal antibody MK-3475 . J. Clin. Oncol.32 ( Suppl. abstr 3005 ), ( 2014 ).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130142"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.3_suppl.3"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.11.2228"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.08.146"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13375"},{"issue":"17","key":"e_1_3_3_11_1","first-page":"30662","article-title":"Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors","volume":"1556","author":"Marchetti A","year":"2017","unstructured":"Marchetti A , BarberisM , FrancoRet al. Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors . J. Thorac. Oncol.S1556\u20130864 ( 17 ), 30662 \u2013 30667 ( 2017 ).","journal-title":"J. Thorac. Oncol."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12340"},{"issue":"9","key":"e_1_3_3_13_1","article-title":"PD-L1 expression in NSCLC: analysis of a large early stage cohort: and concordance of expression in primary, node and metastasis","volume":"10","author":"Mitchell P","year":"2015","unstructured":"Mitchell P , MuroneC , AsadiKet al. PD-L1 expression in NSCLC: analysis of a large early stage cohort: and concordance of expression in primary, node and metastasis . J. Thorac. Oncol.10 ( 9, Suppl.2 S199 abstr ) ( 2015 ).","journal-title":"J. Thorac. Oncol."},{"issue":"8012","key":"e_1_3_3_14_1","article-title":"Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC)","volume":"33","author":"Gainor JF","year":"2015","unstructured":"Gainor JF , SequistLV , ShawATet al. Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC) . J. Clin. Oncol.33 ( Suppl. abstr 8012 ) ( 2015 ).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.27817"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5950"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"e_1_3_3_20_1","first-page":"4719194","article-title":"Mismatch repair deficiency as a predictive biomarker for immunotherapy efficacy","author":"Viale G","year":"2017","unstructured":"Viale G , TrapaniD , CuriglianoG . Mismatch repair deficiency as a predictive biomarker for immunotherapy efficacy . Biomed. Res. Int.2017 , 4719194 ( 2017 ).","journal-title":"Biomed. Res. Int."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7277"},{"key":"e_1_3_3_22_1","unstructured":"Pembrolizumab in advanced BRCA-mutated breast cancer. ( 2017 ). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03025035 ."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.6.448"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8076"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i35.12420"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1963.10500879"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.2307\/2340521"},{"issue":"321","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01621459.1968.11009219","article-title":"Association and estimation in contingency tables","volume":"63","author":"Mosteller F","year":"1968","unstructured":"Mosteller F . Association and estimation in contingency tables . J. Am. Stat. Assoc.63 ( 321 ), 1 \u2013 28 ( 1968 ).","journal-title":"J. Am. Stat. Assoc."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(96)00075-X"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"74","author":"Cox DR","year":"1972","unstructured":"Cox DR . Regression models and life tables (with discussion) . J. Royal Statis. Soc. ( Series B ) 74 , 187 \u2013 200 ( 1972 ).","journal-title":"J. Royal Statis. Soc."},{"key":"e_1_3_3_34_1","unstructured":"International Rules for Multiple Primary Cancers ICD-O Third Edition . Internal Report No.2004\/02 . Lyon : International Agency for Research on Cancer. IARC ( 2004 )."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603386"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.8192"},{"issue":"10","key":"e_1_3_3_37_1","first-page":"991","article-title":"Transitional cell bladder carcinoma in patients younger than 40 years of age","volume":"51","author":"Madrid Garc\u00eda FJ","year":"1998","unstructured":"Madrid Garc\u00eda FJ , Parra MuntanerL , Rivas EscuderoJAet al. Transitional cell bladder carcinoma in patients younger than 40 years of age . Arch. Esp. Urol.51 ( 10 ), 991 \u2013 994 ( 1998 ).","journal-title":"Arch. Esp. Urol."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050992"},{"issue":"2","key":"e_1_3_3_39_1","first-page":"227","article-title":"Bladder tumor in young patients: a series of 26 cases. Comparison with a review of literature","volume":"13","author":"Blanchard JM","year":"2003","unstructured":"Blanchard JM , GrazianaJP , BonnalJLet al. Bladder tumor in young patients: a series of 26 cases. Comparison with a review of literature . Prog. Urol.13 ( 2 ), 227 \u2013 233 ( 2003 ).","journal-title":"Prog. Urol."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.159"},{"issue":"5","key":"e_1_3_3_41_1","first-page":"S38","article-title":"Melanoma in adolescents and young adults (ages 15\u201339 years), United States, 1999\u20132006","volume":"65","author":"Weir HK","year":"2011","unstructured":"Weir HK , MarretLD , CokkinidesVet al. Melanoma in adolescents and young adults (ages 15\u201339 years), United States, 1999\u20132006 . J. Am. Acad. Dermatol.65 ( 5 Suppl. 1 ), S38 \u2013 S49 ( 2011 ).","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.06.002"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2013-0057"},{"issue":"3","key":"e_1_3_3_44_1","first-page":"194","article-title":"Immunosenescence: implications for cancer immunotherapy in elderly patients","volume":"23","author":"Garcia B","year":"2006","unstructured":"Garcia B , LageA . Immunosenescence: implications for cancer immunotherapy in elderly patients . Biotecnol. Apl.23 ( 3 ), 194 \u2013 201 ( 2006 ).","journal-title":"Biotecnol. Apl."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.08.003"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2015.1018417"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2017-0167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:29:16Z","timestamp":1715941756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2017-0167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.2217\/imt-2017-0167"],"URL":"https:\/\/doi.org\/10.2217\/imt-2017-0167","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}